Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 253

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 253
---
 days of the closing of the PIPE Financing (or within 90 calendar days if the SEC reviews the registration statement), subject to acceleration under certain circumstances. We will also agree, among other things, to indemnify each participating holder, their officers, directors, members, employees, and agents, successors and assigns, and each other person, if any, who controls such participating holder within the meaning of the Securities Act of 1933, as amended (the “Securities Act”), under the registration statement from certain losses, claims, damages, liabilities and expenses incident to our obligations under the Registration Rights Agreement. Stockholder Support Agreements In connection with the execution of the Subscription Agreement, Kaken and Aadi entered into the Support Agreements with each of the directors and executive officers of Aadi, certain of their affiliates, and one other significant stockholder of Aadi, who collectively beneficially own or control an aggregate of approximately [●]% of the outstanding shares of Aadi’s common stock as of the Record Date. The Support Agreements provide that, among other things, each of the stockholders has agreed to vote or cause to be voted all of the shares of Aadi - 175 -

common stock beneficially owned by such stockholder as of the record date of the Special Meeting in favor of the Subscription Agreement, the Divestiture and the other transactions contemplated by the Subscription Agreement, as well as certain other transactions, at the Special Meeting. The PIPE Investors include entities that are related to Casey Castelein, M.D., Anupam Dalal, M.D., Behzad Aghazadeh, Ph.D. and Baiteng Zhao, who serve on our board of directors, as well as an executive officer for the year ended December 31, 2024, Bryan Ball. The following table presents the number of shares purchased and the total purchase price paid by these entities and individuals.

| Investor                           |     | Shares    
 Purchased |           |     | Warrants  
 Purchased |           |     | Total     
 Purchase  
 Price ($) |               |
| Entities affiliated with Avoro (1) |     |           |         0 |     |           | 8,333,000 |     |           | 19,998,366.70 |
| Entities affiliated with Acuta (2) |     |           | 1,561,000 |     |           |         0 |     |           |  3,746,400.00 |
| Entities affiliated with KVP (3